Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zardavas, Dimitrios, Meisel, Alexander, Samaras, Panagiotis, Knuth, Alexander, Renner, Christoph, Pestalozzi, Bernhard C., Stenner-Liewen, Frank
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2011
Témata:
Published: January 2011
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082484/
https://ncbi.nlm.nih.gov/pubmed/21526001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000323804
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky